Marc Carrier/X
Aug 18, 2025, 23:53
Radiotherapy and VTE Risk: Insights from Marc Carrier and Colleagues
Marc Carrier, Professor at Ottawa Hospital Research Institute, recently has shared a post on X:
“Radiotherapy is essential in cancer care, but evidence shows it may independently raise the risk of VTE.
This review in RPTH journal highlights mechanisms, diagnostic challenges, and why tailored thromboprophylaxis, not blanket use, is needed.”
Read the full article here.
Title: Radiotherapy—the not-so-insignificant contributor to cancer-associated venous thrombosis
Authors: Gerard Gurumurthy, Jacob Miller, Marc Carrier, Alok Khorana, Jecko Thachil
Stay informed on all science in Hematology with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis